Given the amount of change the company is going thru at the moment EBIT/NPAT need to be treated with a high degree of caution. It is very easy to capitalise costs during the development phase, and when things are not going quite to plan this can be abused. RSG is under pressure to deliver and meet it's forecasts, without the oxide surprise this qtr you would have to question the company's ability to meet it's targets. It is clear to me that development costs are over-running, how this will wash out thru the accounts in future we will have to wait and see.......Simply put, NPAT and EBIT have minimal value when a company is undergoing this level of change/development.
Ann: Production Update December Quarter, page-58
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $1.543B | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 40.5¢ | 37.5¢ | $22.35M | 57.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14881 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 668567 | 8 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| RSG (ASX) Chart |
